Your six-week-old nephew has been coughing for ten days. At first, everyone assumed it was a cold. Then the coughing fits began — violent, gasping episodes that leave him breathless, his lips turning blue for a terrifying moment before he draws a deep, whooping breath. A rushed visit to the paediatrician confirms the nightmare diagnosis: pertussis, or whooping cough. Despite being "vaccinated," how did this happen?
This scenario plays out in thousands of Indian households every year. India accounts for a staggering 26.5% of all pertussis cases globally, yet the disease remains chronically underdiagnosed and underreported. With a global resurgence underway — over 9.4 lakh cases reported by WHO in 2024 alone — pertussis is firmly back in the spotlight. This guide gives every Indian parent, caregiver, and adult the knowledge to recognise, prevent, and manage whooping cough.
What Is Pertussis (Whooping Cough)?
Pertussis is a highly contagious bacterial respiratory infection caused by Bordetella pertussis. It earns the colloquial name "whooping cough" from the high-pitched whooping sound patients make when they gasp for air after a coughing fit. The disease is one of the most infectious known to medicine — a single infected person can spread it to 12-17 others in an unvaccinated population (basic reproduction number R₀ ≈ 12–17).
Why Is It So Dangerous in India?
India uses the whole-cell pertussis vaccine (DTwP) in its Universal Immunisation Programme (UIP), which generally provides stronger and longer-lasting immunity than the acellular pertussis (DTaP) vaccines used in Western countries. However:
- Coverage gaps persist: Only about 85% of children complete the full primary DTwP series nationally, leaving 15% completely unprotected
- Waning immunity: Even after a complete childhood vaccination series, immunity wanes by adolescence — adults can contract and transmit pertussis even if vaccinated as children
- No national booster policy: India currently has no formal national policy for Tdap (tetanus-diphtheria-pertussis) booster doses for adolescents, adults, or pregnant women — a critical gap
- Misdiagnosis: Pertussis in adolescents and adults is frequently misdiagnosed as bronchitis or asthma, allowing unrecognised spread
The result? India carries the world's single largest national burden of pertussis cases.
Three Stages of Whooping Cough
Pertussis is deceptive because it begins with ordinary cold symptoms and only reveals its true nature weeks later. Clinicians describe three distinct phases:
Stage 1: Catarrhal Stage (Weeks 1–2)
This is the most contagious period, yet the least recognisable:
- Runny nose (coryza)
- Low-grade fever
- Mild, occasional cough
- Red, watery eyes
Crucially, infected people are most contagious during this stage — before anyone suspects pertussis. A single visit to a paediatrician's waiting room can seed an entire outbreak.
Stage 2: Paroxysmal Stage (Weeks 2–8)
This is when pertussis declares itself:
- Paroxysmal coughing fits: Clusters of 5–20 rapid coughs in a single breath, leaving the patient completely breathless
- "Whoop": The gasping, high-pitched inspiratory sound as the patient struggles to inhale — more common in children; adults may simply wheeze or vomit after coughing
- Post-tussive vomiting: Vomiting immediately after a coughing fit (a strong clinical clue)
- Cyanosis: Lips or face turning blue during severe fits in infants
- Apnoea: Pauses in breathing — a medical emergency in infants under 6 months
Stage 3: Convalescent Stage (Weeks 8–12+)
- Coughing gradually lessens in frequency and severity
- Can last 3-4 months — pertussis is sometimes called the "100-day cough" (sau din ki khansi in colloquial usage)
- Secondary respiratory infections (pneumonia) are common in this stage
Pertussis in Infants vs Adults: Different Presentations
The disease looks very different across age groups, which contributes to missed diagnoses:
| Feature | Infants (<6 months) | Older Children | Adolescents & Adults |
|---|---|---|---|
| Whoop sound | Often absent | Classic | Often absent |
| Coughing fits | Present | Severe | Mild-moderate |
| Apnoea | Common, life-threatening | Rare | Very rare |
| Vomiting | Common | Common | Common |
| Severity | Can be fatal | Moderate-severe | Mild (but highly infectious) |
| Typical misdiagnosis | Bronchiolitis, sepsis | Asthma | Chronic bronchitis |
Why infants under 6 months are most at risk: They are either unvaccinated (the first dose is given at 6 weeks) or have received only one dose, with no time to build full immunity. This is precisely why maternal Tdap vaccination during pregnancy is so powerful — antibodies pass to the baby before birth.
How Pertussis Is Diagnosed in India
Your doctor will consider clinical history, examination, and laboratory tests. Unlike TB (where a single test often suffices), pertussis diagnosis often requires a combination of approaches:
Laboratory Tests
| Test | How It Works | Best Time to Use | Cost (Private Labs) |
|---|---|---|---|
| Nasopharyngeal PCR (gold standard) | Detects Bordetella pertussis DNA | Within 3 weeks of cough onset | ₹2,500–4,500 (SRL, Dr. Lal PathLabs, Thyrocare) |
| Bacterial Culture | Grows bacteria from NP swab | Within 2 weeks of cough onset | ₹1,500–3,000 |
| Serology (anti-PT IgG) | Detects antibodies | Best after 3+ weeks of illness | ₹2,000–3,500 |
| Clinical diagnosis | Classic symptoms + exposure history | Any time | No lab cost |
Practical note for India: PCR testing for pertussis is not universally available across tier-2 and tier-3 cities. Many Indian doctors still rely on clinical diagnosis, especially when laboratory confirmation would significantly delay treatment. If your doctor suspects pertussis and begins treatment before results return, that is appropriate practice.
Chest X-Ray
A chest X-ray may be ordered to rule out secondary bacterial pneumonia, the most dangerous complication of pertussis.
Treatment: What Works and What Doesn't
Antibiotics (for both treatment and post-exposure prophylaxis)
Antibiotics are most effective when started within the first 3 weeks of illness. After that, they do not significantly shorten illness duration but remain important to reduce transmission.
The antibiotics of choice in India are:
| Drug | Dose | Duration | Indian Brand Names |
|---|---|---|---|
| Azithromycin (first-line) | Adults: 500 mg Day 1, then 250 mg Days 2–5 | 5 days | Azithral, Zithromax, Azee |
| Clarithromycin | Adults: 500 mg twice daily | 7 days | Claribid, Klaricid |
| Erythromycin (alternative) | 500 mg four times daily | 14 days | Erytop, Althrocin |
| Co-trimoxazole | Used if macrolides not tolerated | 14 days | Bactrim, Septran |
For infants under 1 month: Azithromycin is preferred; erythromycin should be avoided due to risk of pyloric stenosis (infantile hypertrophic pyloric stenosis).
Hospitalisation: When Is It Needed?
Immediate hospital admission is required if:
- Infant under 6 months with any coughing episode
- Apnoea (breathing stops) or cyanosis (lips turning blue)
- Feeding difficulties and poor weight gain in infants
- Oxygen saturation below 95%
- Signs of pneumonia
Supportive Care at Home
For mild-to-moderate cases managed at home:
- Rest in a calm, quiet environment — stimulation can trigger coughing fits
- Small, frequent feeds — vomiting after coughing can cause dehydration
- Avoid exposure to irritants like smoke, dust, and cooking fumes
- No cough suppressants: Standard over-the-counter cough medicines are not effective and should not be given to infants
- Isolation: Infected persons should remain at home and wear a mask for at least 5 days after starting antibiotics
Prevention: Vaccination Is the Only Real Protection
India's Universal Immunisation Programme (UIP) Schedule
The DTwP vaccine (combined diphtheria-tetanus-whole-cell pertussis) is provided free at all government health centres:
| Dose | Age | Vaccine | Where |
|---|---|---|---|
| Primary 1 | 6 weeks | DTwP + HepB + Hib (Pentavalent vaccine) | Govt. health centre, free |
| Primary 2 | 10 weeks | Pentavalent vaccine | Govt. health centre, free |
| Primary 3 | 14 weeks | Pentavalent vaccine | Govt. health centre, free |
| Booster 1 | 16–24 months | DTwP | Govt. health centre, free |
| Booster 2 | 5–6 years | DTP (diphtheria-tetanus-pertussis) | Govt. health centre, free |
IAP (Indian Academy of Pediatrics) additionally recommends:
- Tdap booster at 10–12 years for adolescents
- Tdap for all adults who have not received it before, especially:
- New parents (cocoon strategy — protecting the newborn by vaccinating everyone around them)
- Healthcare workers
- Grandparents and caregivers of infants
Tdap Booster: The Critical Missing Link in India
The Tdap vaccine (tetanus-diphtheria-acellular pertussis, for adolescents and adults) is the single most important tool being underused in India. It provides pertussis protection along with a booster for tetanus and diphtheria. Currently, Tdap is:
- Available only in the private sector (not included in the national UIP for adolescents/adults)
- Cost: ₹500–1,000 per dose at private hospitals and vaccination centres
- Recommended once for every adult who has not received it, and once per pregnancy by leading national and international health bodies
Popular Indian Tdap products include Boostrix (GSK) and Adacel (Sanofi).
Tdap During Pregnancy: The Most Powerful Protection for Your Newborn
WHO and IAP recommend Tdap during every pregnancy, ideally between 27–36 weeks. Here is why this matters so profoundly:
When a mother receives Tdap in the third trimester, her body produces anti-pertussis antibodies that cross the placenta and are present in the baby from birth — before the baby can be vaccinated. Studies show this maternal immunisation strategy:
- Reduces whooping cough in babies under 2 months by 78%
- Prevents 9 in 10 hospitalisations in young infants from pertussis
- Provides protection during the most vulnerable window (birth to first dose at 6 weeks)
In India, Tdap in pregnancy is currently not included in the national antenatal care protocol — a significant policy gap. Discuss Tdap with your gynaecologist at your antenatal visits. If you are tracking your antenatal tests and vaccinations, this is one to add.
Post-Exposure Prophylaxis (PEP)
If someone in your household is diagnosed with pertussis, all close contacts should receive a course of azithromycin regardless of vaccination status. PEP is most effective when started within 21 days of exposure.
Who Is at Highest Risk?
- Unvaccinated or incompletely vaccinated infants under 6 months — highest risk of death
- Infants born prematurely — underdeveloped respiratory reserve
- Adolescents and adults — waned immunity from childhood vaccination
- Pregnant women — can pass pertussis to the newborn
- Immunocompromised individuals — those on steroids, chemotherapy, or with HIV
- Healthcare workers — high exposure risk, can transmit to vulnerable patients
Potential Complications
Without timely treatment, pertussis can be life-threatening:
- Pneumonia — the most common serious complication, affecting up to 20% of infants
- Apnoea and hypoxia — particularly dangerous in young infants
- Seizures — from severe hypoxia or rarely from bacterial toxins
- Encephalopathy — brain damage from severe hypoxia
- Rib fractures — from prolonged violent coughing in adults
- Urinary incontinence and hernias — from sustained coughing pressure in adults
- Subconjunctival haemorrhage — burst blood vessels in the eyes from coughing
The overall case-fatality rate in India for infants under 6 months is estimated at 1–4%, significantly higher in rural areas with delayed access to care.
Tracking Recovery with MedicalVault
Managing a household case of pertussis involves multiple tests (PCR, CBC, chest X-ray), multiple prescriptions, and sometimes hospital discharge summaries. Keeping all of this organised is critical — especially if you are coordinating care for a young infant across a paediatric specialist and a general practitioner.
MedicalVault's report management and trend tracking features let you upload and organise all your medical documents in one place, share specific reports with your child's doctor or specialist, and track recovery markers over time. For families managing a long illness like pertussis, having instant access to complete medical history can make a meaningful difference to the quality of care your child receives.
Key Takeaways
- Pertussis (whooping cough) is caused by Bordetella pertussis and remains a serious public health problem in India — the country carries 26.5% of global cases
- The disease progresses through three stages: catarrhal (most contagious), paroxysmal (most severe), and convalescent (lingering cough for up to 3 months)
- Infants under 6 months are at highest risk of severe disease, including apnoea, pneumonia, and death
- India's childhood vaccination programme provides good early protection, but immunity wanes by adolescence — Tdap boosters are urgently needed
- Azithromycin is the first-line antibiotic — start within 3 weeks of symptom onset for best effect
- Maternal Tdap vaccination in pregnancy (27–36 weeks) is the single most powerful tool to protect newborns — discuss it with your gynaecologist
- Keep all vaccination records, test reports, and treatment summaries organised — MedicalVault makes this easy for the whole family
Consult your paediatrician or physician at the first sign of prolonged coughing in any family member, especially infants. Early detection and treatment prevent both suffering and spread.